RegisterLogin

BWC0977 (formic)

CAT: 0804-HY-162959A-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-162959A-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BWC0977 formic is an antibacterial agent that inhibits bacterial DNA replication via inhibition of DNA gyrase and topoisomerase IV. BWC0977 formic exhibits a minimum inhibitory concentration (MIC90) of 0.03-2 µg/mL against MDR (Multi-Drug Resistant) Gram-negative bacteria[1].
CAS Number
[3027162-72-4]
UNSPSC
12352005
Target
Bacterial; DNA/RNA Synthesis; Topoisomerase
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Purity
98.91
Smiles
O=C1N(C)C2=C(CCNC[C@H]3CN(C4=CN=C(OCC(N5)=O)C5=N4)C(O3)=O)C(F)=CC=C2C=C1.OC=O
Molecular Formula
C23H23FN6O7
Molecular Weight
514.46
References & Citations
[1]Shahul Hameed P, et al. BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections. Clinical Trial Nat Commun. 2024 Sep 18;15 (1) :8202.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Topoisomerase

Related Products

CatalogName
HY-162959BWC0977
HY-122653A-01CCT367766 (formic)
HY-16138A-01Ivaltinostat (formic)
HY-161242A-01CBI1 (formic)
HY-134813AMRTX1133 (formic)
HY-101489A-01GZD856 (formic)
HY-11038D-01Zelavespib (formic)
HY-147330B-01SJ1008030 (formic)
HY-150254A-01SLB1122168 (formic)
HY-122858A-01PKCiota-IN-2 (formic)

Alternative Products

CatalogName
T201074-01BWC0977
T63074-01Ivaltinostat formic
MBS5798095MRTX1133 formic
MBS5819586CCT367766 formic
558647Formic acid
MBS5819615SJ1008030 formic
T78160SLB1122168 formic
89990470-25gFormic hydrazide
T210302-01Zelavespib formic
T64087-01GZD856 formic

Popular Products